Endurant Capital Management LP Rvl Pharmaceuticals PLC Transaction History

Endurant Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$2.8 - $3.99 $1.44 Million - $2.05 Million	-514,239 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.34 - $4.28 $549,146 - $1 Million	234,678 Added 83.95%	514,239 $1.95 Million
Q1 2019 May 15, 2019	BUY	$3.6 - $8.75 $171,046 - $415,738	47,513 Added 20.48%	279,561 $1.01 Million
Q4 2018 Feb 14, 2019	BUY	$6.25 - $9.2 $1.45 Million - $2.13 Million	232,048 New	232,048 $1.8 Million

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.